Airborne fungi may underlie chronic sinusitis

	Tweet

Exaggerated immune responses to common airborne fungi seem to be the basic cause of chronically inflamed nasal passages and sinuses in at least some patients with rhinosinusitis, according to a new report.

Although airborne fungal spores enter the airways and lungs when we inhale, the authors explain, they rarely cause illnesses in healthy individuals. Nonetheless, anti-fungal drugs applied to the nasal passages do improve symptoms for many people with chronic rhinosinusitis.

Dr. Hirohito Kita from the Mayo Clinic in Rochester, Minnesota, and colleagues investigated the theory that patients with chronic rhinosinusitis have an exaggerated immune response to common airborne fungi by testing blood specimens and nasal secretions from 18 affected patients and 15 normal individuals.

Less than a third of the rhinosinusitis patients showed anti-fungus antibodies of the type that would indicate an allergic response, the authors report in the Journal of Allergy and Clinical Immunology. However, the participants with chronic rhinosinusitis did have significantly higher blood levels of other antibody types to various fungi than did normal subjects.

Also, blood cells from the affected patients produced more inflammatory factors in response to exposure to fungi than did cells from normal individuals.

The amount of inflammation-promoting substances in nasal secretions also differed markedly between the two groups.

“There is a hypersensitivity response to fungi in patients with chronic Sinusitis, which may not be documented by skin prick test,” Kita told Reuters Health.

“We expect that the reduction of fungal exposure will help to reduce the immune response and subsequent inflammation in the sinuses,” the researcher added. “This can be accomplished by environmental control (e.g., less moisture and less fungi in the house) and treatment with anti-fungal agents.”

However, it is not clear if fungus exposure is the culprit in all people with chronic Sinusitis, Kita noted. “We still do not know that whether this mechanism operates in 100 percent of patients or only 50 percent of patients.”

SOURCE: Journal of Allergy and Clinical Immunology, October 8, 2004. 

RELATED STORIES:
Influenza monitoring by the US military   Asthma Is Most Prevalent Underlying Illness Among Most Serious H1N1 Cases   Flu shots urged for Katrina evacuees, elderly   A benefit of flu: protection from asthma?   Americans piled up Tamiflu on bird flu fear   8 ways to avoid the flu naturally   H1N1 pandemic spreading too fast to count: WHO   Vietnam man has bird flu, 2nd in a month - report   Who to blame for flu? Maybe the U.S., study finds   Birdflu far more deadly than SARS, WHO says   More birds with H5N1 found in China but details are guesswork!   More Americans should get flu shot: experts

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]